[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
August 12, 2009

Aspirin as Adjuvant Therapy for Colorectal CancerA Promising New Twist for an Old Drug

Author Affiliations

Author Affiliations: Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

JAMA. 2009;302(6):688-689. doi:10.1001/jama.2009.1145

Even before the time of Hippocrates, willow extracts, which contain salicylates, were used in medicine as analgesic, anti-inflammatory, and antipyretic agents. Acetylsalicylic acid was isolated in the mid-19th century, and since 1899 when it was patented, aspirin has enjoyed global popularity. The relatively recent discovery of its antiplatelet activity has also led to the widespread use of aspirin as an antistroke and cardioprotective agent, but the list of its medical applications continues to increase.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×